Drug Type Small molecule drug |
Synonyms CDK2-based molecular glue degraders - Monte Rosa Therapeutics, cyclin dependent kinase 2 degraders(Monte Rosa Therapeutics AG), Research programme: cyclin dependent kinase 2 degraders - Monte Rosa Therapeutics |
Target |
Mechanism CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 01 Apr 2022 | |
Ovarian Cancer | Preclinical | US | 01 Apr 2022 |